Use of 52-mg levonorgestrel-releasing intrauterine system in adolescents and young adult women: 3-year follow-up

ECF de Oliveira, T Baêta, RCF Cotta… - Journal of Pediatric and …, 2023 - Elsevier
Abstract Study Objective To evaluate continuance rates, bleeding patterns, and patient
satisfaction with 52-mg levonorgestrel-releasing intrauterine system (LNG-IUS) use in …

[HTML][HTML] Five-year Contraceptive Use of 52-mg Levonorgestrel Releasing Intrauterine System in Young Women, Menstrual Patterns, and New Contraceptive Choice

ECF Oliveira, ALL Rocha - Revista Brasileira de Ginecologia e …, 2023 - SciELO Brasil
Objective To evaluate the continuation rates of the 52-mg levonorgestrel-releasing
intrauterine system (LNG-IUS) during the first 5 years of use, reasons for its discontinuation …

Continuation Rates of the 52-mg Levonorgestrel-releasing Intrauterine System according to the Primary Reason for its Use

L Miranda, MH de Sousa, A Faundes… - Revista Brasileira de …, 2021 - thieme-connect.com
Objective To evaluate whether continuation rates with the 52-mg levonorgestrel-releasing
intrauterine system (LNG-IUS) up to 5 years after placement differed between women using …

Usage of the levonorgestrel-releasing intrauterine system (LNG-IUS) in adolescence: what is the evidence so far?

M Patseadou, L Michala - Archives of gynecology and obstetrics, 2017 - Springer
Purpose The levonorgestrel-releasing intrauterine system (LNG-IUS) is an effective method
of contraception, while also providing various non-contraceptive benefits. Although targeted …

[HTML][HTML] Consecutive use of the 52 mg levonorgestrel-releasing intrauterine system: variations in bleeding patterns

BZ Wittmann, I Monteiro, C Juliato… - Revista Brasileira de …, 2020 - SciELO Brasil
Objective Changes in bleeding patterns could influence the decisions of healthcare
professionals to change the levonorgestrel-releasing intrauterine system (LNG-IUS) before 7 …

Pregnancy outcomes associated with extended use of the 52-mg 20 μg/day levonorgestrel-releasing intrauterine system beyond 60 months: a chart review of 776 …

L Bahamondes, A Fernandes, MV Bahamondes… - Contraception, 2018 - Elsevier
Objective To assess the contraceptive performance of the 52-mg 20 μg/day levonorgestrel-
releasing intrauterine system (LNG-IUS, Mirena; Bayer Oy, Turku, Finland) among women …

Indications and reasons for discontinuing the levonorgestrel-releasing intrauterine system (LNG-IUS)

MLL Pires, AI Souza, MLBR Dantas… - Revista Brasileira de …, 2020 - SciELO Brasil
Objectives: to identify the main indications and reasons for discontinuing the use of the
Levonorgestrel-Releasing Intrauterine System (LNG-IUS). Methods: a cross-sectional study …

Expulsion and continuation rates of the 52 mg levonorgestrel intrauterine system in adolescents and adult women

E Brull, HC Machado, L Bahamondes… - The European Journal …, 2023 - Taylor & Francis
Objective To compare the continuation rates, expulsion, and other reasons for
discontinuation of the hormonal intrauterine device with 52 mg of levonorgestrel (52 mg LNG …

Levonorgestrel intrauterine device use for medical indications in nulliparous adolescents and young adults

BI Schwartz, M Alexander, LL Breech - Journal of Adolescent Health, 2021 - Elsevier
Abstract Purpose Intrauterine devices (IUDs) are highly effective at preventing pregnancy.
Levonorgestrel (LNG) IUDs also have beneficial effects on menstrual bleeding and …

Reasons for satisfaction with the use of the 52‐mg levonorgestrel intrauterine system

M Laporte, CM Charles, S Metelus… - … of Gynecology & …, 2022 - Wiley Online Library
Objectives To assess the reasons to use, reasons they liked, satisfaction with, and
possibilities of recommendation to other women of the levonorgestrel 52‐mg intrauterine …